Logo image
Methods to Generate Genetically Engineered Mouse Models of Soft Tissue Sarcoma
Book chapter   Open access

Methods to Generate Genetically Engineered Mouse Models of Soft Tissue Sarcoma

Rebecca D. Dodd, Leonor Añó, Jordan M. Blum, Zhizhong Li, David Van Mater and David G. Kirsch
Mouse Models of Cancer, pp.283-295
Methods in Molecular Biology, Springer New York
01/06/2015
DOI: 10.1007/978-1-4939-2297-0_13
PMCID: PMC5612825
PMID: 25636474
url
https://www.ncbi.nlm.nih.gov/pmc/articles/5612825View
Open Access

Abstract

We discuss the generation of primary soft tissue sarcomas in mice using the Cre-loxP system to activate conditional mutations in oncogenic Kras and the tumor suppressor p53 (LSL-KrasG12D/+; p53flox/flox). Sarcomas can be generated either by adenoviral delivery of Cre recombinase, activation of transgenic Cre recombinase with tamoxifen, or through transplantation of isolated satellite cells with Cre activation in vitro. Various applications of these models are discussed, including anticancer therapies, metastasis, in vivo imaging, and genetic requirements for tumorigenesis.
Cancer Genetically engineered mouse models Mouse models Sarcoma Satellite cells Transgenic mice

Details

Metrics

17 Record Views
Logo image